Navigation Links
LifeCycle Pharma to Initiate Phase II Clinical Trial of LCP-Tacro for Organ Transplantation

LifeCycle Pharma will initiate a Phase II clinical trial of LCP-Tacro for the prevention of organ rejection in kidney transplant patients following the update of its initial Investigational New Drug Application (IND) in the United States (U.S.)

LifeCycle Pharma has also reached protocol agreement with the U.S. Food and Drug Administration (FDA) for its first Phase II trial in kidney transplant recipients.

LifeCycle Pharma A/S (OMX:LCP) today announced it will initiate a Phase II clinical trial program using LCP-Tacro to prevent organ rejection in kidney transplant patients. The clinical trial protocol has been reviewed by the FDA, and LifeCycle Pharma has revised it to be in line with FDA recommendations. As a result, LifeCycle Pharma expects to initiate a Phase II clinical trial soon.

The trial is designed as a conversion study in stable kidney transplant recipients, with patients being switched to LCP-Tacro once-a-day from Prograf(R) twice-a-day. Up to 60 patients will be investigated at 10-12 sites in the U.S. and Canada, and the initial clinical trial results are expected by year end 2007, or early 2008. This study is considered to form the basis for initiation of a subsequent Phase III program in de-novo kidney transplant recipients.

A Phase II clinical study in liver transplant recipients is expected to follow this year.

"The initiation of the Phase II study using LCP-Tacro is a step forward in the development of our organ transplantation franchise," said Dr. Flemming Ornskov, President and CEO of LifeCycle Pharma. "We are encouraged by the progress LifeCycle Pharma has made, and eager to advance LCP-Tacro to Phase II clinical trials," added Dr. Ornskov.

"This is the start of an exciting clinical development program. LCP-Tacro will bring the convenience of once-daily administration of tacrolimus and may optimize outcomes after kidney transplantation," said Dr. Shamkant Mulg
'"/>




Page: 1 2

Related medicine news :

1. LifeCycle Pharma Forms Scientific Advisory Board in Solid Organ Transplantation
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Pharma cos must forge Strategic alliances
5. Medicis Pharmaceutical company enters pediatric market
6. Pharma majors gear to supply anti-anthrax drug
7. Pharmacies in for a dose of bitter medicine
8. Andhra Pradesh to set up Pharma City
9. Sun Pharma to launch chiral version of omeprazole soon
10. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
11. Pharmacia may take 51.5 percent Abbott stake
Post Your Comments:
(Date:9/22/2014)... 2014 (HealthDay News) -- All sexually active women ... common sexually transmitted infections: chlamydia and gonorrhea, according ... Task Force. The task force noted ... 24 years of age and pregnant women. ... noticeable symptoms. As a result, many infections go ...
(Date:9/22/2014)... September 22, 2014 Manhattan residents who ... side of the hip , which could be bursitis ... This treatment is now offered at New York Dynamic ... called trochanteric bursitis, occurs when the trochanteric bursa becomes ... in the hip, between the iliotibial band and the ...
(Date:9/22/2014)... Alan Mozes HealthDay Reporter ... Many American parents are aware of online physician-rating sites, and ... for their children, according to a new national study. ... parents -- further suggest that negative online ratings may dissuade ... been recommended by a neighbor. Conversely, a positive online ...
(Date:9/22/2014)... a founding partner in the Global STEM Alliance, a ... talent in science, technology, engineering and math (STEM) around ... of Sciences (NYAS), Malaysian Prime Minister Najib Razak participated ... , With the goal of developing over 1,000,000 aspiring ... the initiative will create a host of learning opportunities, ...
(Date:9/22/2014)... An inventor and anesthesiologist applied what ... of side-sleeping. "My lower arm always became numb when ... solution to this problem," she said. "It’s better to ... your arm 'fall asleep.'" , The Sleeping Pillow enables ... more comfortably. It avoids pain and restlessness by reducing ...
Breaking Medicine News(10 mins):Health News:Screen Women for Chlamydia, Gonorrhea, Experts Say 2Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 2Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 3Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3
... of Children,s Health indicates 31 percent of Missouri children ... activity requirements for students and nutritional standards for school ... study from the University of Missouri shows Jump Into ... in changing unhealthy youth behaviors. JIA aims to ...
... Ltd., a medical device company publicly traded on the ... European Journal of Heart Failure, a peer reviewed ... the results of a 72-patients, randomized, controlled study which ... the home setting can significantly relieve symptoms of heart ...
... , Scientists at the University of Granada have ... pregnant women may be a factor associated with spontaneous abortion, a ... never been proven in humans before. For the purpose of ... 265 women, 132 had suffered a spontaneous miscarriage during that year. ...
... have long been an attractive class of drug candidates ... fewer potential side effects. Dr. Andrei Yudin, Professor, ... new and effective process that makes linear peptides circular, ... more effectively and increase their stability compared to linear ...
... that mutate to resist drug treatment survive by establishing tiny ... penetrate the cell membrane making the cancer insensitive to ... a new way to break that resistance and shut off ... forcibly activate a heat-shock protein called Hsp27. This protein regulates ...
... Sept. 28 (HealthDay News) -- Just like extremely premature babies, ... impaired lung function at ages 8 to 9, but in ... time they are teenagers, research shows. "There has been ... premature birth can have on the lung function of children, ...
Cached Medicine News:Health News:Students 'jump into action' for better health 2Health News:European Journal of Heart Failure publishes new randomized controlled clinical study of RESPeRATE 2Health News:Low zinc and copper levels might cause spontaneous abortion 2Health News:Low zinc and copper levels might cause spontaneous abortion 3Health News:OGI and MaRS Innovation invest in peptide therapeutics 2Health News:Scientists shut down pump action to break breast cancer cells' drug resistance 2Health News:Scientists shut down pump action to break breast cancer cells' drug resistance 3Health News:Lung Function of Late Preemies May Improve With Age 2
(Date:9/22/2014)... 22, 2014  For many people experiencing issues ... facing the prospect of large, painful incisions and ... activities are also impacted, such as working, driving ... the problem, some patients even delay necessary treatment, ... lead to permanent damage for some conditions. ...
(Date:9/22/2014)... 22, 2014  CorMedix Inc. (NYSE MKT: CRMD), ... therapeutic products for the prevention and treatment of ... announce that TUV-SUD and The Medicinal Evaluation Board ... has granted its request for a label expansion ... initially approved in July 2013 for use in ...
(Date:9/22/2014)... -- Thoratec Corporation (NASDAQ: THOR ), a ... save, support and restore failing hearts, announced today that ... and Chief Executive Officer, effective immediately.  Mr. Grossman succeeds ... his executive and Board roles but will remain as ... of 2016.  Mr. Grossman has served ...
Breaking Medicine Technology:Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions 2Neutrolin Label Expansion Approved for the European Union 2Neutrolin Label Expansion Approved for the European Union 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 2Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 4Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 5
...  Merrimack Pharmaceuticals, Inc. announced today that the first ... clinical study combining MM-121, a fully human monoclonal ... irinotecan (Camptosar®) in patients with advanced cancers. ... The Phase 1 study evaluates the safety and ...
... Md., Dec. 13, 2011 The U.S. Food and ... device intended to aid in the detection of life-threatening ... spectroscopy. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... health care providers identify patients with critical head injuries ...
Cached Medicine Technology:Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121 in Combination with Cetuximab and Irinotecan in Patients with Advanced Cancers 2FDA Permits Marketing of the First Hand-Held Device To Aid in the Detection of Bleeding In The Skull 2FDA Permits Marketing of the First Hand-Held Device To Aid in the Detection of Bleeding In The Skull 3
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L...
The Proteineer suite integrates powerful mass spectrometers with robotics and bioinformatics to deliver maximum productivity in high-throughput proteomics....
The ProteomeLab PA 800 resolves and quantifies proteins by their isoelectric point and molecular weight, generates high-resolution peptide maps and carbohydrate profiles and provides front-end separa...
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110....
Medicine Products: